The Tissue‐Engineered Small‐Diameter Artery

The characteristics proposed for an “ideal” tissue-engineered small-diameter artery include the following:1–4 It is biocompatible, that is, nonthrombogenic and nonimmunogenic, and resistant to infection as well (all of which are associated with a confluent nonactivated endothelium). Moreover, it results in an acceptable woundhealing response (without fibrosis). It possesses appropriate mechanical properties, including physiological compliance (viscoelasticity) and, critically, adequate strength, without any propensity for permanent creep that leads to aneurysm. It possesses physiological transport properties, that is, appropriate permeability to solutes and cells. Finally, it exhibits key physiological properties, such as vasoconstriction/ relaxation responses. From a practical standpoint, suturability and simplicity of handling are necessary, and, from a commercial standpoint, it must be fabricated in a process that scales well with quantity and be a product that can be shipped and stored. There are four main approaches currently being investigated, all of which satisfy an apparent preqrequisite to biocompatibilty of a small-diameter graft—that no permanent synthetic materials are used. One approach is acellular, based on implanting decellularized tissues treated to enhance biocompatibility, strength, and cell adhesion/invasion leading to cellularization with host cells.5 The other three approaches involve implantation of constructs possessing some degree of cellularity. The most recent of these is based on the concept of self-assembly, wherein cells are cultured on tissue culture plastic in medium inducing high ECM synthesis.6,7 This leads to sheets of neotissue that are subsequently processed into multilayer tubular form. The other two approaches rely on a polymeric scaffold. One is based on forming a tube of a synthetic biodegradable polymer and then seeding the cells (which would not survive the conditions of polymer synthesis), relying on active cell invasion or an applied force to achieve cellularity.8–11 The other is based on a tube of a biopolymer, typically a reconstituted type I collagen gel,12,13 formed with and compacted by tissue cells, where an appropriately applied mechanical constraint to the compaction yields circumferential alignment of fibrils and cells characteristic of the arterial media.14–16 It is this last feature that is most attractive about a biopolymer-based tissue-

[1]  Y. Imai,et al.  Transplantation of a tissue-engineered pulmonary artery. , 2001, The New England journal of medicine.

[2]  Robert M. Nerem,et al.  Dynamic Mechanical Conditioning of Collagen-Gel Blood Vessel Constructs Induces Remodeling In Vitro , 2000, Annals of Biomedical Engineering.

[3]  F A Auger,et al.  A completely biological tissue‐engineered human blood vessel , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Robert T. Tranquillo,et al.  Long-Term Cyclic Distention Enhances the Mechanical Properties of Collagen-Based Media-Equivalents , 2003, Annals of Biomedical Engineering.

[5]  M S Conte,et al.  The ideal small arterial substitute: a search for the Holy Grail? , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  R Langer,et al.  Morphologic and mechanical characteristics of engineered bovine arteries. , 2001, Journal of vascular surgery.

[7]  P. Hagen,et al.  Remodeling of an acellular collagen graft into a physiologically responsive neovessel , 1999, Nature Biotechnology.

[8]  R Langer,et al.  Creation of viable pulmonary artery autografts through tissue engineering. , 1998, The Journal of thoracic and cardiovascular surgery.

[9]  Robert T Tranquillo,et al.  Elastic fiber production in cardiovascular tissue-equivalents. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[10]  L. Germain,et al.  A human tissue‐engineered vascular media: a new model for pharmacological studies of contractile responses , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  R M Nerem,et al.  Tissue engineering a blood vessel substitute: the role of biomechanics. , 2000, Yonsei medical journal.

[12]  R T Tranquillo,et al.  Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. , 2002, Journal of biomedical materials research.

[13]  J. Mayer,et al.  Tissue engineering of cardiovascular structures. , 1997, Current opinion in cardiology.

[14]  R T Tranquillo,et al.  A fibrin-based arterial media equivalent. , 2003, Journal of biomedical materials research. Part A.

[15]  R. Tranquillo,et al.  Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation. , 2000, Journal of biomechanical engineering.

[16]  L. Niklason Techview: medical technology. Replacement arteries made to order. , 1999, Science.

[17]  R T Tranquillo,et al.  Engineered alignment in media equivalents: magnetic prealignment and mandrel compaction. , 1998, Journal of biomechanical engineering.

[18]  F A Auger,et al.  In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. , 1993, Journal of vascular surgery.

[19]  R T Tranquillo,et al.  Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. , 2002, Biomaterials.

[20]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.